Kensey Nash Evaluating Aegis Vortex Atherectomy System In Pilot Study
This article was originally published in The Gray Sheet
Executive Summary
Kensey Nash's recently initiated pilot study for its Aegis Vortex System (AVS) for treating occluded saphenous vein grafts is designed to support FDA approval for an estimated 300-patient pivotal trial.